New Drug Product: Susvimo
This slideshow shows drug information for Susvimo. Click here for the complete Susvimo monograph.
Age-Related Macular Degeneration
Susvimo Approved for Wet Age-Related Macular Degeneration
Susvimo delivers ranibizumab via ocular implant, which is surgically inserted into the eye during a one-time, outpatient procedure and refilled every 6 months.
Faricimab Gets Priority Review for Wet AMD, Diabetic Macular Edema
The BLA submission is based on positive results across four phase 3 studies in wet AMD and DME.
7 Steps Patients Should Take to Prevent Age-Related Macular Degeneration
February is AMD and Low Vision Awareness Month. There are several modifications patients can make to their lifestyles that may help reduce their risk of AMD.
